These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 17516615

  • 1. Therapy with immunosuppressive drugs and biological agents and use of contraception in patients with rheumatic disease.
    Østensen M, von Esebeck M, Villiger PM.
    J Rheumatol; 2007 Jun; 34(6):1266-9. PubMed ID: 17516615
    [Abstract] [Full Text] [Related]

  • 2. The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes.
    Chakravarty EF, Sanchez-Yamamoto D, Bush TM.
    J Rheumatol; 2003 Feb; 30(2):241-6. PubMed ID: 12563675
    [Abstract] [Full Text] [Related]

  • 3. Drugs in pregnancy. Rheumatological disorders.
    Østensen M.
    Best Pract Res Clin Obstet Gynaecol; 2001 Dec; 15(6):953-69. PubMed ID: 11800535
    [Abstract] [Full Text] [Related]

  • 4. Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers.
    Viktil KK, Engeland A, Furu K.
    Scand J Rheumatol; 2012 May; 41(3):196-201. PubMed ID: 22401133
    [Abstract] [Full Text] [Related]

  • 5. Rheumatoid arthritis, alcohol, leflunomide and methotrexate. Can changes to the BSR guidelines for leflunomide and methotrexate on alcohol consumption be justified?
    Rajakulendran S, Gadsby K, Deighton C.
    Musculoskeletal Care; 2008 Dec; 6(4):233-45. PubMed ID: 18702106
    [Abstract] [Full Text] [Related]

  • 6. Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study.
    Weber-Schoendorfer C, Chambers C, Wacker E, Beghin D, Bernard N, Network of French Pharmacovigilance Centers, Shechtman S, Johnson D, Cuppers-Maarschalkerweerd B, Pistelli A, Clementi M, Winterfeld U, Eleftheriou G, Pupco A, Kao K, Malm H, Elefant E, Koren G, Vial T, Ornoy A, Meister R, Schaefer C.
    Arthritis Rheumatol; 2014 May; 66(5):1101-10. PubMed ID: 24470106
    [Abstract] [Full Text] [Related]

  • 7. Adjunctive anakinra in patients with active rheumatoid arthritis despite methotrexate, or leflunomide, or cyclosporin-A monotherapy: a 48-week, comparative, prospective study.
    Karanikolas G, Charalambopoulos D, Vaiopoulos G, Andrianakos A, Rapti A, Karras D, Kaskani E, Sfikakis PP.
    Rheumatology (Oxford); 2008 Sep; 47(9):1384-8. PubMed ID: 18603660
    [Abstract] [Full Text] [Related]

  • 8. [Do DMARDs contibute to impaired healing after surgery? Should they be discontinued before surgery?].
    Glück T, Müller-Ladner U.
    Dtsch Med Wochenschr; 2007 Sep; 132(37):1901-4. PubMed ID: 17823884
    [No Abstract] [Full Text] [Related]

  • 9. Medical treatment of adolescents with rheumatic disease.
    Hollister JR.
    Adolesc Med; 1998 Feb; 9(1):163-70, vii. PubMed ID: 10961259
    [Abstract] [Full Text] [Related]

  • 10. Combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis.
    Lee SS, Park YW, Park JJ, Kang YM, Nam EJ, Kim SI, Lee JH, Yoo WH, Lee SI.
    Scand J Rheumatol; 2009 Feb; 38(1):11-4. PubMed ID: 19191187
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Disease specific problems related to drug therapy in pregnancy.
    Ostensen M.
    Lupus; 2004 Feb; 13(9):746-50. PubMed ID: 15485116
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort study.
    Weber-Schoendorfer C, Hoeltzenbein M, Wacker E, Meister R, Schaefer C.
    Rheumatology (Oxford); 2014 Apr; 53(4):757-63. PubMed ID: 24369411
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis.
    Metzler C, Miehle N, Manger K, Iking-Konert C, de Groot K, Hellmich B, Gross WL, Reinhold-Keller E, German Network of Rheumatic Diseases.
    Rheumatology (Oxford); 2007 Jul; 46(7):1087-91. PubMed ID: 17519271
    [Abstract] [Full Text] [Related]

  • 17. Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases.
    Asten P, Barrett J, Symmons D.
    J Rheumatol; 1999 Aug; 26(8):1705-14. PubMed ID: 10451066
    [Abstract] [Full Text] [Related]

  • 18. Leflunomide-associated infections in rheumatoid arthritis.
    Jenks KA, Stamp LK, O'Donnell JL, Savage RL, Chapman PT.
    J Rheumatol; 2007 Nov; 34(11):2201-3. PubMed ID: 17937473
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.